GRAIL, Inc. Operating Cash Flow
GRAIL, Inc. (GRAL) reported Operating Cash Flow of -$167.72 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- GRAIL, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$80.73M.
- GRAIL, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$86.99M.
- GRAIL, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$63.78M.
- GRAIL, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$63.24M.
- GRAIL, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$299.01M.
- GRAIL, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$577.16M.
- GRAIL, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$595.80M.
- GRAIL, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$561.31M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$80.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$167.72M 10-Q · filed 2026-08-06 | -$231.50M derived: sum of 3 quarters · filed 2026-08-06 | -$294.75M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$86.99M 10-Q · filed 2026-05-07 | -$150.77M derived: sum of 2 quarters · filed 2026-05-07 | -$214.02M derived: sum of 3 quarters · filed 2026-05-07 | -$290.98M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$63.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$127.03M derived: sum of 2 quarters · filed 2026-03-12 | -$204.00M derived: sum of 3 quarters · filed 2026-08-06 | -$299.01M 10-K · filed 2026-03-12 |
| 2025-09-30 | -$63.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$140.21M derived: sum of 2 quarters · filed 2026-08-06 | -$235.22M 10-Q · filed 2025-11-13 | -$328.71M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$76.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$171.98M 10-Q · filed 2026-08-06 | -$265.47M derived: sum of 3 quarters · filed 2026-08-06 | -$370.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$95.01M 10-Q · filed 2026-05-07 | -$188.50M derived: sum of 2 quarters · filed 2026-05-07 | -$293.08M derived: sum of 3 quarters · filed 2026-05-07 | -$464.88M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$93.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$198.07M derived: sum of 2 quarters · filed 2026-03-12 | -$369.87M derived: sum of 3 quarters · filed 2026-03-12 | -$577.16M 10-K · filed 2026-03-12 |
| 2024-09-30 | -$104.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$276.38M derived: sum of 2 quarters · filed 2025-11-13 | -$483.67M 10-Q · filed 2025-11-13 | -$612.56M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | -$171.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$379.08M 10-Q · filed 2025-08-13 | -$507.98M derived: sum of 3 quarters · filed 2026-03-12 | -$665.49M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | -$207.29M 10-Q · filed 2025-05-14 | -$336.18M derived: sum of 2 quarters · filed 2026-03-12 | -$493.69M derived: sum of 3 quarters · filed 2026-03-12 | |
| 2023-12-31 | -$128.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$286.41M derived: sum of 2 quarters · filed 2026-03-12 | -$595.80M 10-K · filed 2025-03-05 | |
| 2023-10-01 | -$157.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$466.90M 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | -$309.39M 10-Q · filed 2024-08-13 | |||
| 2023-01-01 | -$561.31M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |